Our xTAG® and MultiCode®-RTx Technologies serve a wide range of clinical applications, including infectious disease testing, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.

Read More

Research & Applied Markets

Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.

Read More


Become a Partner

Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® Technology. Click here to start the conversation now.

Learn More


Luminex® Blog

The Faces of Luminex: Christine Valle, Global Marketing

Here at Luminex, each system we develop has a dedicated team managing every detail of the instruments, reagents, specifications, and more. For our xMAP® Technology, that team is led by Christine Valle, Director of Global Systems & Consumables Marketing. The proud Texas native came to Luminex in 2011 and holds a bachelor’s degree from Sam Houston State University.

Continue Reading >

Using Luminex to Help Treat Respiratory Patients



Dr. Gonzalez is a family practitioner who treats an eclectic mix of patients, young and old. He runs a smart practice and knows the value of syndromic testing as well as when a targeted approach makes better sense, especially when testing for a potential respiratory illness. Watch how he works to strategically treat two types of patients with respiratory infections.

Watch more videos >

Luminex on Twitter

In the ever-changing regulatory and reimbursement landscape, control and flexibility over #GI, #bloodstream, &…
h J R
We all ❤ the rapid results molecular #GI panels offer, but could use more control over pathogens tested & panel des…
h J R
The Guava easyCyte System is a versatile benchtop platform for additional, multi-dimensional cell health assessment…
h J R

Latest News

March 5
Luminex Corporation to Present at the Barclays Global Healthcare Conference

February 8
Luminex Corporation Declares First Quarter Cash Dividend

February 4
Luminex Corporation Reports Fourth Quarter and Full-Year 2018 Financial Results

January 2
Luminex Corporation Completes Acquisition of MilliporeSigma’s Flow Cytometry Portfolio

November 5
Luminex Corporation Reports Third Quarter 2018 Financial Results


APHL Annual Meeting
June 3-6
St. Louis, MO

ASM Microbe 2019
June 20-24
San Francisco, CA

CYTO 2019
June 23-26
Vancouver, BC